1. Home
  2. CIGL vs ABSI Comparison

CIGL vs ABSI Comparison

Compare CIGL & ABSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CIGL

Concorde International Group Ltd Class A Ordinary Shares

HOLD

Current Price

$1.99

Market Cap

417.7M

ML Signal

HOLD

Logo Absci Corporation

ABSI

Absci Corporation

HOLD

Current Price

$4.79

Market Cap

357.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CIGL
ABSI
Founded
1997
2011
Country
Singapore
United States
Employees
134
N/A
Industry
Diversified Commercial Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
417.7M
357.9M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
CIGL
ABSI
Price
$1.99
$4.79
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$6.96
AVG Volume (30 Days)
68.1K
5.3M
Earning Date
05-15-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
10.64
EPS
N/A
N/A
Revenue
N/A
$4,534,000.00
Revenue This Year
N/A
$215.96
Revenue Next Year
N/A
$319.10
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.40
$2.24
52 Week High
$25.00
$6.72

Technical Indicators

Market Signals
Indicator
CIGL
ABSI
Relative Strength Index (RSI) 56.54 51.29
Support Level $1.55 $2.51
Resistance Level $2.28 $5.23
Average True Range (ATR) 0.16 0.57
MACD 0.01 -0.14
Stochastic Oscillator 69.49 13.68

Price Performance

Historical Comparison
CIGL
ABSI

About CIGL Concorde International Group Ltd Class A Ordinary Shares

Concorde International Group Ltd is an integrated security services provider that combines physical manpower and technology to deliver effective security solutions. The company offers a range of services to enhance security and safety: (1) i-Guarding Services; (2) Man-Guarding Services; and (3) Consultancy and Training Services. Its i-Guarding Services leverages technology to increase efficiency, with a mobile platform and cluster aggregation model of a higher skillset workforce. It has two operating segments, which are (i) security services; and (ii) training school. Key revenue is generated from Security Services.

About ABSI Absci Corporation

Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.

Share on Social Networks: